Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)
Clinical trial NCT04465916 · TERMINATED
Trial details
- NCT number
- NCT04465916
- Sponsor
- Enyo Pharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2021-06-17
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.